Evaluation of Exparel Adductor Canal Field Block for Pain Control After ACL Reconstruction

Summary

This is a prospective, randomized study for adult patients presenting to the Carilion Clinic Institute of Orthopedics and Neurosurgery. Patients undergoing isolated ACL reconstruction will be eligible for inclusion. All patients will receive an adductor canal block (either with bupivacaine or Exparel. Patients will be given a pain diary for self-report of pill counts, pain scores, block duration, and pain control satisfaction). Pill counts and pain scores will also be taken by a team member at two and six-week post-operative visits. Primary outcomes include opioid requirements and pain scores.

Timeline

Start

2021-02-16

Primary completion

2022-02-16

Completion

2022-03-02

Drugs

Indications

No indication recorded.